NASDAQ · Financial Statements
CollPlant Biotechnologies Ltd (OPHI) Revenue, Earnings & Financial Statements
$3.58
NASDAQ: OPHI
Market Cap $6.76M
Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)
Full income statement, balance sheet, and cash flow statement for CollPlant Biotechnologies Ltd (OPHI), plus valuation and return ratios.
Annual financials are not yet available for this stock.
Revenue and earnings of other Medical - Specialties stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.